Researchers identified polyphenolics and isoquinoline alkaloids as potential antiviral agents against monkeypox virus by targeting viral elements. Natural extracts from traditional plants also show promise. Urgent molecular studies are needed to confirm their anti-poxvirus properties.
T. caucasicum and S. rosmarinus essential oils inhibit A. flavus growth and AFB production by 20.61-89.16%. Down-regulate aflR gene. Potential for controlling fungal contamination in food crops.
Rosemary shows neuroprotective properties in studies, inhibiting cholinesterase and modulating dopamine and oxytocin systems. It has antidepressant and anxiolytic effects and may improve memory. More research, including placebo-controlled studies, is needed. Rosemary constituents could have potential as drugs for Alzheimer's disease.
Nanoencapsulation of Salvia rosmarinus Speen and Cedrus atlantica Manetti essential oil mixture in Gum Arabic improves stability, antifungal activity against brown rot fungi, and thermal properties. Potential as a sustainable wood preservative for green building.
Researchers investigated the effects of rosemary extract on airway inflammation in asthmatic rats. The extract showed anti-oxidative and anti-inflammatory properties, suggesting that it could be beneficial for treating respiratory conditions.
The study investigated the antioxidant activity of extracts from the rosemary plant. The extracts were found to contain beneficial compounds that could potentially reduce lipid accumulation in NAFLD.
Review finds that plant-based drugs, particularly herbs, used as add-on therapy for COVID-19 show efficacy and safety, potentially enhancing the immune system for treating the virus. (37 words)
This study investigated the neuroprotective effects of carnosic acid (extracted from Salvia rosmarinus) in an in vitro model of Alzheimer's disease (AD). Carnosic acid improved neuronal survival by suppressing apoptosis and restored synaptic impairments by increasing expression levels of brain-derived neurotrophic factor (BDNF), postsynaptic density protein-95 (PSD-95), and synaptophysin (Syn). These effects were dependent on inhibiting the phosphorylation of N-methyl-D-aspartate receptors (NMDARs) and its downstream cascades. Carnosic acid could potentially be a targeted candidate for the treatment of AD.